Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Curr Opin Pharmacol. 2013 Jul 9;13(4):641–645. doi: 10.1016/j.coph.2013.06.007

Figure 2. Rationally designed therapeutic possibilities for TB in the eicosanoid pathway.

Figure 2

Shown are the pathways we have found to dysregulate TNF levels with possible interventional strategies to restore eicosanoid balance in boxes. The predicted effect of all interventions except the LTB4DH inducer and the LXA4 receptor antagonist have been confirmed in the zebrafish TB model.